Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,295 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Exploiting the curative potential of adoptive T-cell therapy for cancer.
Hinrichs CS, Rosenberg SA. Hinrichs CS, et al. Among authors: rosenberg sa. Immunol Rev. 2014 Jan;257(1):56-71. doi: 10.1111/imr.12132. Immunol Rev. 2014. PMID: 24329789 Free PMC article. Review.
Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes.
Hwu P, Schwarz S, Custer M, Smith CA, Mulé JJ, Rosenberg SA. Hwu P, et al. Among authors: rosenberg sa. J Immunol Methods. 1992 Jul 6;151(1-2):139-47. doi: 10.1016/0022-1759(92)90112-7. J Immunol Methods. 1992. PMID: 1321199
Gene therapy for cancer.
Rosenberg SA. Rosenberg SA. JAMA. 1992 Nov 4;268(17):2416-9. JAMA. 1992. PMID: 1404800
Clinical application of IL6 in cancer therapy.
Mulé JJ, Marcus SG, Yang JC, Weber JS, Rosenberg SA. Mulé JJ, et al. Among authors: rosenberg sa. Res Immunol. 1992 Sep;143(7):777-9. doi: 10.1016/0923-2494(92)80023-e. Res Immunol. 1992. PMID: 1439156 Clinical Trial. No abstract available.
The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy.
Mulé JJ, Jicha DL, Rosenberg SA. Mulé JJ, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Oct;12(3):196-8. doi: 10.1097/00002371-199210000-00011. J Immunother (1991). 1992. PMID: 1445811
Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.
Topalian SL, Hom SS, Kawakami Y, Mancini M, Schwartzentruber DJ, Zakut R, Rosenberg SA. Topalian SL, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Oct;12(3):203-6. doi: 10.1097/00002371-199210000-00013. J Immunother (1991). 1992. PMID: 1445813 Review.
A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.
Lange JR, Raubitschek AA, Pockaj BA, Spencer WF, Lotze MT, Topalian SL, Yang JC, Rosenberg SA. Lange JR, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Nov;12(4):265-71. doi: 10.1097/00002371-199211000-00007. J Immunother (1991). 1992. PMID: 1477077 Clinical Trial.
In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells.
Sanda MG, Bolton E, Mulé JJ, Rosenberg SA. Sanda MG, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Aug;12(2):132-7. doi: 10.1097/00002371-199208000-00008. J Immunother (1991). 1992. PMID: 1504054
Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy.
Sherry RM, Pass HI, Rosenberg SA, Yang JC. Sherry RM, et al. Among authors: rosenberg sa. Cancer. 1992 Apr 1;69(7):1850-5. doi: 10.1002/1097-0142(19920401)69:7<1850::aid-cncr2820690729>3.0.co;2-i. Cancer. 1992. PMID: 1551067 Clinical Trial.
Detection of antigen specific T lymphocytes by determination of intracellular calcium concentration using flow cytometry.
Alexander RB, Bolton ES, Koenig S, Jones GM, Topalian SL, June CH, Rosenberg SA. Alexander RB, et al. Among authors: rosenberg sa. J Immunol Methods. 1992 Apr 8;148(1-2):131-41. doi: 10.1016/0022-1759(92)90166-q. J Immunol Methods. 1992. PMID: 1564323
1,295 results
Jump to page
Feedback